Project
Market Strategy: Defining and Embedding Global Market Access Excellence Across the Organization of a Large Pharmaceutical Company
Situation
- The new global head of market access of a global pharmaceutical company, with a focus on orphan diseases, had the objective to reduce time between US launch and reimbursement in international countries, and enable faster access to new geographies
- Market access strategy was not core to global decision making within the organization, which had led to suboptimal pricing and reimbursement for recently launched products
Solution
- Internal situation assessment through over 20 interviews with senior management
- Cross functional alignment through various workshops to define market access excellence, the mission, vision, and role of the market access department, and ways of working
- Definition of access deliverables, a consistent approach to develop them, and standardization through templates
Impact
- Market access strategy development stronger embedded in the organization, for example through standardized template slides in the global brand plan
- Alignment across the organization on the importance of market access, what is required to be successful, and ways of working between departments
"In a short time we have come a very long way to align the organization on the mission, vision, merit, and ways of working for global market access. We finally are in a good shape to address the challenges we face"